Details:

Corporate Authors:
United States. Agency for International Development. ; Centers for Disease Control and Prevention (U.S.) ; National Institute of Allergy and Infectious Diseases (U.S.) ;
United States. Agency for International Development. ; Centers for Disease Control and Prevention (U.S.) ; National Institute of Allergy and Infectious Diseases (U.S.) ; Less -
Description:
The U.S. Government’s (USG) tuberculosis (TB) program is mainly implemented through USAID as the lead agency in international TB control, in close collaboration and coordination with U.S. Centers for Disease Control and Prevention (CDC), Department of State/ The Office of the Global AIDS Coordinator (OGAC), the National Institutes of Health (NIH), and Department of Defense (DoD). The U.S. Government continues to prioritize support to countries with high rates of TB and multi-drug resistant TB (MDR-TB), lagging case detection, poor program performance, and where the HIV epidemic is a driver of TB disease. This prioritization of countries led to investments in 20 “Tier 1” or focus countries, with funding levels of at least $3 million per country; and in 21 “Tier 2” countries, with smaller but strategically targeted interventions.
Document Type:
Pamphlet (or booklet) ;
Genre:
Annual Reports ;
Collection(s):
Stephen B. Thacker CDC Library collection
Main Document Checksum:
[+]
urn:sha256:6b9b76e7f91d645e553ba7adf8f3f11849ac32804f7aee4a7e7339b21eb1d687
File Type:

Supporting Files

• No Additional Files

More +